Skip to main content

Table 2 Drug resistance in cancer mediated by m7G regulators

From: Biological roles of RNA m7G modification and its implications in cancer

m7G regulators

Tumors

Drug

Function

mechanism

References

METTL1

Colon cancer

Cisplatin

Increase drug sensitivity

Regulate miR149-3p/S100A4/P53 axis

[106]

METTL1, WDR4

Hepatocellular carcinoma

Lenvatinib

Decrease drug sensitivity

Promote the translation of EGFR

[107]

METTL1

Nasopharyngeal carcinoma

Cisplatin and Docetaxel

Decrease drug sensitivity

Activate WNT/β- catenins/EMT pathway

[76]

WDR4

Hepatocellular carcinoma

Sorafenib

Decrease drug sensitivity

Promote the translation of CCNB1

[11]

METTL1

Cervical cancer

5-Fluorouracil

Decrease drug sensitivity

Lead to rapid tRNA(ValAAC) decay

[108]

WBSCR22

Colon cancer

oxaliplatin

Decrease drug sensitivity

Reduce intracellular ROS and 8-oxoG

[55]